Point-of-Care Manufacturing of CD20.19 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cells in a Standard Academic Cell Processing Flexibility for a Phase I Clinical Trial in Relapsed, Refractory NHL

导出原文传递

翻译打印收藏纠错

作者： Zhu, Fenlu ^[1] ; Shah, Nirav N. ^[2] ; Schneider, Dina ^[3] ; Xu, Huiqing ^[4] ; Chaney, Katherine ^[5] ; Luib, Lawrence ^[6] ; Keever-Taylor, Carolyn A. ^[7] ; Dropulic, Boro ^[8] ; Orentas, Rimas ; Hari, Parameswaran ; Johnson, Bryon

作者单位： Med Coll Wisconsin, Div Hematol & Oncol, CIBMTR, Milwaukee, WI 53226 USA ^[1] Med Coll Wisconsin, Dept Med, Brookfield, WI USA ^[2] Froedtert Hosp, Milwaukee, WI USA ^[3] Lentigen Technol Inc, Gaithersburg, MD USA ^[4] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA ^[5] Med Coll Wisconsin, Med, Milwaukee, WI 53226 USA ^[6] Lentigen, Gaithersburg, MD USA ^[7] Med Coll Wisconsin, Milwaukee, WI 53226 USA ^[8]

发布时间 2020-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交